Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sexually Transmitted Diseases (STD) Testing Market, by Disease Type
1.4.2 Europe Sexually Transmitted Diseases (STD) Testing Market, by Location of Testing
1.4.3 Europe Sexually Transmitted Diseases (STD) Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2019, Oct – 2021, Dec) Leading Players
Chapter 4. Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
4.1 Europe Chlamydia Market by Country
4.2 Europe Herpes simplex virus Market by Country
4.3 Europe Gonorrhea Market by Country
4.4 Europe Syphilis Market by Country
4.5 Europe Human papillomavirus (HPV) Market by Country
4.6 Europe Other Disease Market by Country
Chapter 5. Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
5.1 Europe Laboratory Testing Market by Country
5.2 Europe Point of care (POC) Testing Market by Country
Chapter 6. Europe Sexually Transmitted Diseases (STD) Testing Market by Country
6.1 Germany Sexually Transmitted Diseases (STD) Testing Market
6.1.1 Germany Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.1.2 Germany Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.2 UK Sexually Transmitted Diseases (STD) Testing Market
6.2.1 UK Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.2.2 UK Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.3 France Sexually Transmitted Diseases (STD) Testing Market
6.3.1 France Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.3.2 France Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.4 Russia Sexually Transmitted Diseases (STD) Testing Market
6.4.1 Russia Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.4.2 Russia Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.5 Spain Sexually Transmitted Diseases (STD) Testing Market
6.5.1 Spain Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.5.2 Spain Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.6 Italy Sexually Transmitted Diseases (STD) Testing Market
6.6.1 Italy Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.6.2 Italy Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
6.7 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market
6.7.1 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Disease Type
6.7.2 Rest of Europe Sexually Transmitted Diseases (STD) Testing Market by Location of Testing
Chapter 7. Company Profiles
7.1 BioMérieux S.A.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Abbott Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.3 Becton, Dickinson and Company
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Hologic, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Approvals and Trials:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Thermo Fisher Scientific, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.6 SWOT Analysis
7.6 F. Hoffmann-La Roche Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Product Launches and Product Expansions:
7.7 DiaSorin Molecular LLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 Danaher Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bio-Rad laboratories, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.10. OraSure Technologies, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional & Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
7.10.5.2 Acquisition and Mergers:
Unique Offerings 